Skip to main content
. Author manuscript; available in PMC: 2026 Jun 24.
Published in final edited form as: Am J Kidney Dis. 2025 Dec 6;87(4):540–552.e1. doi: 10.1053/j.ajkd.2025.09.020

Table 2.

Cumulative Incidence of Nephrology Referral Within 12 Months From Albuminuria Detection, Among Individuals Meeting Referral Criteria

After Newly Detected Elevated Albuminuria After Confirmed Elevated Albuminuria
Albuminuria Level Albuminuria Level
No. at Risk Overalla Moderateb Severec Very Severed No. at Risk Overalla Moderateb Severec Very Severed
Swedish criteriae 5,795 28% (27–30) 28% (26–29) 23% (21–25) 37% (34–39) 3,688 42% (40–43) 32% (30–34) 44% (41–48) 66% (62–69)
 Dipstickf 2,831 11% (10–12) 15% (13–17) 7% (6–9) 9% (7–12) 1,470 22% (20–24) 15% (13–18) 24% (19–29) 43% (37–50)
 Quantitative methodf 2,964 45% (43–47) 37% (35–40) 44% (41–48) 64% (60–68) 2,218 55% (53–57) 45% (42–48) 56% (51–60) 76% (72–79)
KDIGO criteriag 5,365 26% (24–27) 20% (19–21) 39% (35–42) 58% (53–62) 6,707 32% (31–33) 30% (29–32) 25% (23–27) 44% (42–47)
a

12-Month cumulative incidence (95% CI).

b

Moderate albuminuria: 30–299 mg/g.

c

Severe albuminuria: 300–999 mg/g.

d

Very severe albuminuria: ≥1,000 mg/g.

e

Based on a combination of age, albumin-creatinine ratio, and eGFR thresholds (see Table S2).

f

Type of test at first detection for individuals with newly detected albuminuria, and type of test at albuminuria confirmation for individuals with confirmed albuminuria.

g

Estimated GFR < 30 mL/min per 1.73 m2 or refractory hypertension after newly detected albuminuria; eGFR < 30 mL/min per 1.73 m2, refractory hypertension or sustained albuminuria ≥ 300 mg/g at retesting.